Pioglitazone: An Ongoing Misery in the Developing Countries to Which I can’t be Pragmatic!
Journal Title: Open Access Journal of Endocrinology - Year 2018, Vol 2, Issue 2
Abstract
In 2014, I've published an article warning against the widespread usage of pioglitazone in the developing countries though it has been banned or heavily restricted in all developed countries due to its proved causation with an increased incidence of bladder carcinoma
Authors and Affiliations
Mina T Kelleni
Gestational Diabetes Mellitus and Ademolus Classification of Hypoglycaemia-A Review
According to the World Health Organization, hyperglycaemia first detected at any time during pregnancy should be classified as either diabetes mellitus in pregnancy, or gestational diabetes mellitus. Current definitions...
Spectrum of Diabetic Kidney Disease in India - A Tertiary Care Centre Experience
Objectives / Aim of study: To assess the magnitude, clinico-social risk factors and associations of diabetic kidney disease in type 2 diabetes subjects attending a tertiary care centre in Eastern India. Materials and Me...
Thyrotoxicosis Associated Channelopathy
We hereby report a case of 47 year-old man of Indian origin whose hyperthyroidism surfaced when he presented with an episode of muscular paralysis in association with hypokalemia. Weakness recovered with the correction o...
Is there an Escalation of Type 2 Diabetes Mellitus in Children and Adolescents: Therapeutics and Preventive Approach
There is an increasing prevalence of type 2 diabetes mellitus (T2DM) in children and adolescents from all over the world from various ethnicities, although the incidence of obesity is not increasing any more. Most of the...
Is it Useful to Perform FNAC in Thyroid Gland Diseases?
Background: Neck masses are usually benign, their clinical importance is primarily related to the need to exclude thyroid cancer Thyroid gland cancer accounts for 1% of all cancers and is responsible for 0.5% of death re...